Profile Details

Create Project

★★★★★

☆☆☆☆☆

USD 35 /hr

★★★★★

☆☆☆☆☆

Hire Dr. Maria Chiara G.

Italy

USD 35 /hr

MD, Ophthalmologist, PhD candidate

Profile Summary

I am an eye doctor and PhD candidate. I have experience in writing scientific papers, preparing presentations and reports. I will use my experience to write or improve different types of medical or scientific texts aimed at a scientific audience. I also have experience in communicating science to a lay audience, which I learned during the science communication fellowship organised by the ARVO (association for research in vision and ophthalmology). I can also offer translation from Italian to English and vice versa.

Subject Matter Expertise

• ☆ Drug Development
• ☆ Pharmaceutical Regulatory Affairs
• ☆ Orthoptics
• ☆ Ophthalmology
• ☆ Neuro-Ophthalmology
• ☆ Oncology
• ☆ Ophthalmic Surgery
• ☆ Ophthalmic Plastic & Reconstructive Surgery
• ☆ Inflammation
• ☆ Regulatory Writing
• ☆ Technical & Scientific Writing
• ☆ Science Communication

Services

• Writing

Writing Medical Writing, Technical Writing, Copywriting, Translation

Work Experience

PhD candidate

Leiden University Medical Center

January 2021 - Present

Medico in formazione (resident)

Università degli Studi di Siena

November 2016 - Present

Education

Regulatory Writing Certificate

University of Chicago

October 2023 - March 2024

Science Communication Training Fellowship

ARVO (Association for Research in Vision and Ophthalmology)

March 2022 - March 2023

Winter School Data Ethics

Eurolife

January 2023 - January 2023

Specializzazione in oftalmologia (Scienze mediche, chirurgiche e neuroscienze)

Università degli Studi di Siena

November 2016 - November 2020

Laurea in medicina e chirurgia

Università degli Studi di Pavia

2009 - 2015

Certifications

• Basic course for clinical investigators (BROK) certification

  NFU - Nederlandse Federatie van Universitair Medische Centra

  September 2022 - Present

• Cambridge English Proficiency C2

  British Council

  December 2010 - Present

Publications

JOURNAL ARTICLE

Maria Chiara Gelmi, Robert M. Verdijk, Laurien E. Houtzagers, Pieter A. van der Velden, Wilma G. M. Kroes, Gregorius P. M. Luyten, T. H. Khanh Vu, Martine J. Jager (2023). Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma . International Journal of Molecular Sciences.

Maria Chiara Gelmi, Robert M Verdijk, Laurien Houtzagers, Pieter A. van der Velden, Wilma G. M. Kroes, Gregorius P. M. Luyten, T. H. Khanh Vu, Martine Jager (2023). Microphthalmia-Associated Transcription Factor: A Differentiation Marker in Uveal Melanoma . International Journal of Molecular Sciences.

Maria Chiara Gelmi, Laurien E. Houtzagers, Thomas Strub, Imène Krossa, Martine J. Jager (2022). MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance . International Journal of Molecular Sciences.

Maria Chiara Gelmi, Laurien Houtzagers, Thomas Strub, Imène Krossa, Martine Jager (2022). MITF in Normal Melanocytes, Cutaneous and Uveal Melanoma: A Delicate Balance . International Journal of Molecular Sciences.

Wierenga, A.P.A., Brouwer, N.J., Gelmi, M.C., Verdijk, R.M., Stern, M.-H., Bas, Z., Malkani, K., van Duinen, S.G., Ganguly, A., Kroes, W.G.M., et al.(2022). Chromosome 3 and 8q Aberrations in Uveal Melanoma Show Greater Impact on Survival in Patients with Light Iris versus Dark Iris Color . Ophthalmology.

Miracco, C., Toti, P., Gelmi, M.C., Aversa, S., Baldino, G., Galluzzi, P., de Francesco, S., Petrelli, F., Sorrentino, E., Belmonte, G., et al.(2021). Retinoblastoma is characterized by a cold, CD8+ Cell Poor, PD-L1− microenvironment, which turns into hot, CD8+ cell rich, PD-L1+ after chemotherapy . Investigative Ophthalmology and Visual Science. 62. (2).

(2020). New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy . Mediators of inflammation.

Fabiani, C., Sota, J., Sainz-De-La-Maza, M., Pelegrín, L., Emmi, G., Lopalco, G., Iannone, F., Vannozzi, L., Guerriero, S., Gelmi, M.C., et al.(2020). New potential weapons for refractory scleritis in the era of targeted therapy . Mediators of Inflammation. 2020.

Francesco Martino, Maria Chiara Gelmi, Paolo Galluzzi, Sonia De Francesco, Clelia Miracco, Doris Hadjistilianou(2020). Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade Syndrome . Ocular Oncology and Pathology. 6. (6). p. 430--437. S. Karger {AG}

Martino, F., Gelmi, M.C., Galluzzi, P., De Francesco, S., Miracco, C., Hadjistilianou, D.(2020). Orbital Pseudocellulitis: A Retinoblastoma-Associated Masquerade Syndrome . Ocular Oncology and Pathology. 6. (6). p. 430-437.

Fruschelli, M., Capozzoli, M., Gelmi, M.C., Masi, G., Annunziata, P.(2019). Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing–remitting multiple sclerosis . International Ophthalmology. 39. (4). p. 777-781.

Maria Chiara Gelmi, Mario Fruschelli, Marco Capozzoli, Gianni Masi, Pasquale Annunziata(2018). Longitudinal quantitative assessment of macula during therapy with fingolimod in relapsing–remitting multiple sclerosis . International Ophthalmology. Springer Nature

PREPRINT

Arwin Groenewoud, Gangyin Zhao, Maria-Chiara Gelmi, Jie Yin, Gerda E. M. Lamers, Remco van Doorn, Rob. M. Verdijk, Martine J. Jager, Felix B. Engel, B. Ewa Snaar-Jagalska (2023). Melanin enhances metastatic melanoma colonization by inhibiting ferroptosis .

OTHER

Maria Chiara Gelmi, Arwin Groenewoud, Jie Yin, Samar Alsafadi, Fariba Nemati, Didier Decaudin, Sergio Roman-Roman, Helen Kalirai, Sarah E. Coupland, Aart G. Jochemsen, et al.(2021). Patient-derived zebrafish xenograft models reveal ferroptosis as a fatal and druggable weakness in metastatic uveal melanoma . Cold Spring Harbor Laboratory

Groenewoud, A., Yin, J., Gelmi, M.C., Alsafadi, S., Nemati, F., Decaudin, D., Roman-Roman, S., Kalirai, H., Coupland, S.E., Jochemsen, A.G., et al.(2021). Patient-derived zebrafish xenograft models reveal ferroptosis as a fatal and druggable weakness in metastatic uveal melanoma . bioRxiv.